Mangoceuticals, Inc.
MGRX
$2.49
-$0.08-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.95M | -2.00M | -2.39M | -2.37M | -2.57M |
| Total Depreciation and Amortization | 721.80K | 300.00 | 3.20K | 6.20K | 6.30K |
| Total Amortization of Deferred Charges | -464.30K | 241.60K | 222.70K | -- | -- |
| Total Other Non-Cash Items | 507.20K | 611.50K | 877.40K | 454.40K | 802.20K |
| Change in Net Operating Assets | 54.10K | -20.00K | -289.60K | 915.80K | 61.90K |
| Cash from Operations | -1.13M | -1.17M | -1.58M | -991.10K | -1.70M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 65.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 65.00K | -- | 0.00 |
| Total Debt Issued | -37.50K | 0.00 | 100.00K | 87.50K | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 760.00K | 0.00 | 388.30K | 180.00K | 1.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 400.00K | 750.00K | 1.50M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.12M | 750.00K | 1.99M | 267.50K | 1.20M |
| Foreign Exchange rate Adjustments | -8.20K | -500.00 | -1.10K | -100.00 | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.30K | -416.30K | 474.90K | -723.70K | -497.70K |